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a b s t r a c t
Purpose: Implant-supported overdentures are an alternative predictable rehabilitation
method that has a high impact on improving the patient’s quality of life. However, some
biological complications may interfere with the maintenance and survival of these
overdenture implants. The goal of this article was to assess the factors that affect peri-
implant success, through a hypothetical prediction model for biological complications of
implant overdentures.
Methods: A retrospective observational, prevalence study was conducted in 58 edentulous
Caucasian patients rehabilitated with implant overdentures. A total of 229 implants were
included in the study. Anamnestic, clinical, and implant-related parameters were collected
and recorded in a single database. “Patient” was chosen as the unit of analysis, and a
complete screening protocol was established. The data analytical study included assessing
the odds ratio, concerning the presence or absence of a particular risk factor, by using binary
logistic regression modeling. Probability values (p values) inferior to 0.05 were considered as
representing statistically significant evidence.
Results: The performed prediction model included the following variables: mean probing
depth, metal exposure, IL1B_allele2, maxillary edentulousness, and Fusobacterium nucleatum.
The F. nucleatum showed significant association with the outcome. Introducing a negative
coefficient appeared to prevent complications or even boost the biological defense when
associated with other factors.
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Conclusions: The prediction model developed in this study could serve as a basis for further
improved models that would assist clinicians in the daily diagnosis and treatment planning
practice of oral rehabilitation with implant overdentures.
© 2017 Japan Prosthodontic Society. Published by Elsevier Ltd. All rights reserved.
1. Introduction
The replacement of missing teeth undoubtedly restores
function and aesthetics and improves the patient confidence
and self-esteem [1–4]. In most cases, dental implants are an
alternative rehabilitation method that is predictable and has a
high impact on improving the patient's quality of life [1,2,5,6].
The success and implant survival rates of this method are
considered high (greater than 90%) even with mini dental
implants, in the elderly and in patients suffering from systemic
diseases, such as osteoporosis/osteopenia and diabetes
mellitus [7–16]. However, some factors may interfere with
the maintenance and survival of the implants and respective
prosthetic restorations [17–22]. One of these factors is the
biofilm formation on the implant surface, which has often
been discussed. This factor causes a host response and the
establishment of an inflammatory lesion in the peri-implant
mucosa, which, when perpetuated, may lead to the develop-
ment of peri-implant biological complications that might even
culminate in implant loss [22–25].
The biological complications of peri-implant tissues in-
clude mainly inflammation of the peri-implant mucosa
(mucositis), marginal bone loss (periimplantitis) and, less
often, other soft-tissue complications (fenestration, bone and
gingival tissue dehiscence, hyperplasia, fistulas, among
others) [26]. Nevertheless, according to prospective longitudi-
nal studies of at least five years, the most serious biological
complication is implant loss [27]. Several factors may
contribute to this failure, including infection and/or contami-
nation by pathogenic bacteria, the physical status of the
patient, surgical trauma, excessive and/or early occlusal
loading, unfavorable axial load, smoking, alcohol consump-
tion, history of periodontitis, and history of radiotherapy
[18,27–33].
Therefore, in recent years, we have been witnessing a more
detailed description of the success criteria for dental implants
[25,32]. Initially, these criteria focused only on implant loss but,
more recently, they have started to include other biological
and prosthetic aspects, probably to consider the biological and
functional issues related to peri-implant tissues and prosthet-
ic rehabilitation [23,24,32]. Although high biological success
rates of dental implants and increased predictability of the
osseointegration process have been reported, current research
is focusing its interest on complications of the restorative
phase, which are especially important for implant over-
dentures, as these are related to both biological and prosthetic
factors [34–39].
In the past years, aspects related to individual host
susceptibility have been pointed out, including the associ-
ation of genetic polymorphisms (genome variants) in the
genes of interleukin 1 (IL-1) (IL1A, IL1B and IL1RN) with the
development of peri-implant biological complications and
even implant loss in oral rehabilitation with dental
implants [22,40–54]. It is also believed that when peri-
implant disease onsets after a successful osseointegration
process of a dental implant, it results from an imbalance
between the peri-implant biofilm and the host response
[55]. Moreover, several studies have reported an association
between microbiologic aspects and peri-implant disease
[23,56–63].
Nowadays, research is faced with the challenge of
answering questions concerning the role of biofilm and
genetic polymorphisms in the establishment and progres-
sion of the peri-implant disease. This paper intends to
show how some particular IL-1 gene polymorphisms (889
IL1A, +3953 IL1B, and a variable number tandem repeat
(VNTR) IL1RN) may contribute to evaluating the risk for
biological complications in dental implant overdentures in
a Portuguese Caucasian population. Furthermore, the final
goal of this study was to provide a hypothetical prediction
model for biological complications of dental implant over-
dentures that could become useful in a near future for the
planning of overdentures rehabilitations with dental
implants.
2. Material and methods
2.1. Study subjects
This retrospective observational prevalence study was per-
formed in a population composed of 58 Caucasian patients
from the Northern region of Portugal, who had been rehabili-
tated with oral implant-supported overdentures. A total of
229 implants were included in the study. Patients were
recruited in oral rehabilitation appointments conducted
within the Master’s/Specialization Course on Oral Rehabilita-
tion of the Faculty of Dental Medicine of our University,
between September 2012 and September 2014. The sample size
was determined based on a statistical estimate, with a
confidence interval of 95%, and an estimated error of 6.1%,
according to the reported prevalence of the genetic polymor-
phisms that control the production of interleukin-1 (IL-1) in
several European Caucasian populations [22,64,65], and the
incidence of biological complications in dental implants
[22,27,31,32,64,66–69].
The study was approved by the Ethical Committee of our
Faculty, and the study protocol was outlined following the
legal norms (Declaration of Helsinki and 2005 Strasbourg
Protocol). Informed consent was obtained from all subjects,
and patient privacy was ensured.
The patients were classified into two groups:
 Group A (presence of biological complications/unsuccess-
ful) – patients rehabilitated with dental implant
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overdentures that showed a biological complication in at
least one dental implant.
 Group B (absence of biological complication/successful) –
patients rehabilitated with dental implant overdentures
that showed no biological complications.
A compilation of several criteria for unsuccessful implants
was used for establishing the biological complications consid-
ered in this study [22,31,32,64,66,69,70]. The resulting biologi-
cal complications of implants included the following
situations or entities:
 Peri-implant inflammatory signs (erythema, suppuration
or fistula),
 Mobility,
 Pain,
 Peri-implant mucositis,
 Periimplantitis,
 Loss of dental implant.
Only complications related to implants supporting over-
dentures were recorded in the analysis. The patient that
showed none of these situations was classified in the Group B
(successful); if he presented some of these entities in one or
more implants, it was sufficient to be classified in Group A
(unsuccessful). Any other potential implant in the oral cavity
was not considered for this study.
The inclusion criteria adopted in this study were the
following: adults (at least 18 years) of both sexes that had a
maxillary or mandibular implant-supported overdenture for
at least six months. Patients who had lost all overdenture
supporting implants or who had replaced a lost fixed-
restoration supporting implant with a removable prosthesis
were not included in this investigation. Other exclusion
criteria were: individuals with a history of personal or family
genetic disease, and pregnant, postpartum or breastfeeding
women.
2.2. Data collection
All patients who fulfilled the inclusion criteria and agreed to
participate voluntarily in the study were included. Each
participant answered a structured questionnaire about several
personal data (demographic and social data – sex, age,
education level, and occupation), their general health status
(current diseases, medication, systemic and chronic diseases,
menopause, hormone replacement therapy, neoplastic dis-
eases, and chemotherapy and radiotherapy history), and their
dental history (motive for tooth loss, type of prosthetic
replacement of missing teeth). Behavioral traits (smoking
habits, alcohol consumption, oral hygiene habits, and pros-
thesis hygiene) were also recorded. Participants were ques-
tioned about their smoking habits in the moment of the
examination, in the previous five years, and in the week after
the implant placement surgery. Smoking habits were catego-
rized as “no smoking”, “light smoking” (less than 20 cigarettes
per day), “heavy smoking” (more than 20 cigarettes per day) [1–
3], and “smoking with abstinence” (smoker who abstained
from smoking only in the post-surgery week). Alcohol
consumption was recorded in three categories: wine, beer,
and spirit drinks. For each category, the amount and frequency
of intake were recorded, using glasses or liters as units for
measuring the amount and daily, weekly, monthly, and yearly
basis for frequency [29]. Participants were asked about their
alcohol habits at the time of the observation and in the week
after the implant placement surgery [22].
All patients only underwent an intra-oral examination to
evaluate their general oral health status and the implant,
prosthetic and occlusal conditions. Simultaneously, a radio-
graphic evaluation was conducted, by analyzing the last
control panoramic radiography of each participant (present in
the clinical file).
At the same examination, the genotypic analysis was
blindly performed, without clinical information. The genetic
test was performed using buccal epithelial cells for the
detection of polymorphisms in the IL1A, IL1B, and IL1RN genes
and peri-implant crevicular fluid (collected with paper cones
in an Eppendorf tube) for the molecular identification of four
bacterial specimens (Actinomyces actinomycetemcomitans, Bac-
teroides forsythus, Fusobacterium nucleatum, Porphyromonas
gingivalis). The single nucleotide gene polymorphisms (SNP)
in the IL1A (position 889 in the promoter region) and IL1B
(position +3953 in the fifth exon) genes were detected with the
PCR-RFLP (polymerase chain reaction-restriction fragment
length polymorphism) method (Table 1). The VNTR polymor-
phism found in the intron 2 of the IL1RN gene was detected by
PCR due to the presence of repeats of an 86pb sequence
(Table 2). The molecular identification of bacteria was
performed with the Platinum PCR Supermix 96 and the
composition and length of the primers of each bacterial
species are summarized in Table 3. The scanning and
quantification of PCR products were automatically performed
in agarose gel with the QIAxcel equipment (QIAGEN
1
, Izasa,
Portugal). This identification was carried out after the
restriction reaction in the case of the IL1A (889) and IL1B
(+3953) gene polymorphisms, after the amplification reaction
Table 1 – Amplification products and restriction enzymes used for the detection of polymorphisms in the IL1A and IL1B
genes.
Polymorphisms Primers PCR 50–30 Size of expected product (bp) Restriction enzyme
889 IL1A TTACATATGAGCCTTCCATG 110 Ncol, 65C
AAGCTTGTTCTACCACCTGAACTAGGC
+3953 IL1B CTC AGG TGT CCT CGA AGA AAT CAA A 185 Taql, 37C
GCT TTT TTG CTG TGA GTC CCG
Bp, base pair.
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of intron 2 in the case of the IL1RN gene VNTR polymorphism,
and directly by PCR in the case of bacterial identification. After,
the DNA of each participant was anonymized from irreversible
way.
2.3. Statistical analysis
The collected data were analyzed with the IBM
1
SPSS
1
Statistics 22 (NY Armonk: IBM Corp. 2014) program, using
the most appropriate techniques for the variables involved.
The data analytical study included assessing the odds ratio,
concerning the presence or absence of a particular risk factor,
using binary logistic regression modeling. Probability values
inferior to 0.05 were considered as representing statistically
significant evidence. Clinically, a risk factor was established as
a feature that could predispose an individual to the disease or
condition. Epidemiologically, it was determined as an inde-
pendent variable (cause) likely to modify a dependent variable
(effect). Considering the factors that may lead to biological
complications in oral rehabilitation with overdentures, we
have tried to create an empirical model that would determine
which of these factors were statistically significant in the
process, and, subsequently, assess their odds ratio. For this
purpose, we first conducted a univariate selection of candidate
variables. Then, a forward stepwise technique was used to
optimize variable selection, in order to select a set of variables
that could contribute to the result (presence or absence of
biological complication in overdentures). Categorical variables
were coded in dummy variables, according to the Hosmer–
Lemeshow test [72].
The resultant model should contain all the variables that
were considered essential according to the pre-established
criteria of the pE and pR values (p values of entry and removal
of the variable in the model) selected so that the model
contains only statistically and clinically significant variables.
Thus, even if a variable shows a p value>0.05, it can be forced to
be included in the model, because the individual contribution
of this variable may be very different when acting together
with other variables. Following the guidelines proposed by
Hosmer and Lemeshow [72], it is highly recommended to
choose a pE value within the range of 0.15–0.20.
The apparent performance of the created logistic regres-
sion model was evaluated with the ROC (Receiver Operating
Characteristic) analysis, using the ROC empirical curve and the
correspondent measure of area under the curve [73].
3. Results
The final sample of 58 individuals was composed of
44 females (75.9%) and 14 males (24.1%) (Table 4). Participants
were aged between 50 and 86 years, with an average of
68.8 years and a standard deviation of 8.3 years. The median
was slightly higher (70.0 years) in women compared to men
(67.0 years).
Of the 58 subjects, 32 (55.2%) were classified as Group A
(presence of biological complications) and the remaining 26
(44.8%) as Group B (successful) (Fig. 1). The sample distribution
according to the presence or absence of biological complica-
tion in implant-supported overdentures occurred in the same
way in both sexes. In men, 9 had biological complications
(28.1%), and 5 had successful overdentures (19.2%), while in
women, 23 had biological complications (71.9%) and 21 had
successful overdentures (80.8%) (Table 4). The average age was
68.4 years for Group A and 69.3 years for Group B. The result of
the t-student test (t=0.425, df=56, p=0.672) confirmed that
there were no significant differences in mean age between
subjects with and without biological complications.
Table 2 – Primers used for detecting the IL1RN VNTR polymorphism and its alleles.
Polymorphism Primer PCR 50–30 Alleles (number of repeats/bp)
VNTR IL1RN TCC TGG TCT GCA GGT AA Allele 1 Allele 2 Allele 3 Allele 4 Allele 5
CTC AGC AAC ACT CCT AT 4/410 2/240 3/326 5/498 6/595
Bp, base pair. VNTR allele detection according to Avilla-Campos et al. [71].
Table 3 – Composition and length of the primers of each bacterial species.
Primers Oligonucleotide sequence 50–30 Length (bp)
Actinobacillus actinomycetemcomitans GCT AAT ACC GCG TAG AGT CGG 500
ATT TCA CAC CTC ACT TAA AGG T
Bacteroides forsythus GCG TAT GTA ACC TGC CCG CA 600
TGC TTC AGT GTC AGT TAT ACC T
Fusobacterium nucleatum ATT GTG GCT AAA AAT TAT GAT T 1000
ACC CTC ACT TTG AGG ATT ATA G
Porphyromonas gingivalis AGG CAG CTT GCC ATA CTG CG 400
ACT GTT AGC AAC TAC CGA TGT
Bp, base pair.
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All implants supporting the overdenture at the moment of
the observation were evaluated and the clinical variables are
summarized in Table 5. The total maxillary edentulousness
was 63.8% (N=37) and the partial maxillary edentulousness
was 36.2% (N=21).
The frequency of the biological complications considered is
summarized in Fig. 2. Clinical manifestations of fistula and
mobility/pain were reported in only 1.7% (N=1) of our study’s
sample, which corresponds to one individual positive for each
of these parameters. Suppuration occurred in 8.6% (N=5) of the
sample, erythema in 34.5% (N=20), peri-implant mucositis in
43.1% (N=25) and periimplantitis in 31.0% (N=18). Early
implant loss (15.5%, N=9) occurred more often than late
implant loss (3.4%, N=2).
The univariate logistic regression analysis included the
following slope coefficients: logistic regression containing
only the variable, estimated standard error for the estimated
coefficient, Wald statistics, p value associated with the
statistical coefficient test, estimated odds ratio, and the limits
of the 95% confidence interval for odds ratio (Table 6).
After the statistical stabilization of the model, and
considering the evidence found in the literature that bacteria
are associated with the occurrence of biological complications,
bacteria were included in the multivariate analysis to assess
their joint influence, even though their p values were greater
than 0.20. The F. nucleatum showed significant association with
the outcome in all of the variables found. Introducing a
negative coefficient appeared to prevent complications or
even potentiate the biological defense when associated with
other factors.
After the application of the stepwise forward technique
with pE=0.15 and pR=0.20, the final model was completed with
“biological complication” as the dependent variable (y=0,
absence of biological complication and y=1, presence of
biological complication) and the following selected variables:
mean probing depth, metal exposure, IL1B_allele2, maxillary
edentulousness, and F. nucleatum (Table 7). Apparent internal
validation of the model was performed with the generated ROC
curve analysis (Fig. 3), considering the probability estimated by
the model as a variable test. The result is shown in Table 8.
The final model is the one that has the greatest number of
explanatory variables and obeys the principle of parsimony
[73]. If the area under the ROC curve is 0.950, the model
correctly predicts the outcome in 95% of cases. Thus, the
estimated logit model translates into:
gðxiÞ ¼ B0 þ B1x1 þ ::: þ Bpxp
g(xi)=16.299+3.005*MeanPD+6.247*Metalexposure
+3.224*IL1B_alelle2+1.953*Maxillary edentulousness3.76*
F. nucleatum
In terms of estimated probability, the model would be:
p^ xið Þ ¼
exp gðxiÞð Þ
1 þ exp gðxiÞð Þ
4. Discussion
The size of our sample, although restricted to a specific group
of oral rehabilitation implants (dental implant overdentures),
is similar, and even bigger, to that of other studies that
investigated genetic polymorphisms of interleukin-1 in sub-
jects rehabilitated with dental implants [40,41,43,45,46,48,49].
Nonetheless, it is also smaller than the sample sizes of other
studies on the same area [22,42,44,47,51,52]. In this regard, we
emphasize that the election of a particular type of oral
rehabilitation (overdenture with dental implants) may have
probably contributed to the sample size achieved. However,
we have noted that most of the conducted studies similar to
ours included all types of oral rehabilitation on dental implants
and some of them did not reveal the type of oral rehabilitation
studied [40,42,43,45–47,49,51,52].
In the sample evaluated in this study, 75.9% of the
participants were female and 24.1% male. Some of the studies
mentioned above did not reveal the sex of their participants
[41,42]. However, in most of the studies similar to ours, the
distribution of the sample by sex with female predominance is
the most reported [22,43,44,46–48,51,52]. The average age of our
Fig. 1 – Sample distribution according to the presence (Group
A) or absence (Group B) of biological complications related to
overdenture.
Table 4 – Sample distribution according to sex and age, in the Group A (presence of biological complication) and in the Group B
(absence of biological complications/successful) (N=58).
Group A
(Presence of biological complications)
Group B
(Absence of biological complications/successful)
Total
N % N % N %
Male 9 28.1 5 19.2 14 24.1
Female 23 71.9 21 80.8 44 75.9
Average age (years) 68.4 69.3 68.8
N, number of individuals in the sample.
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sample was higher than that of other research studies on
interleukin-1 genetic polymorphisms in populations rehabili-
tated with dental implants, which reported values ranging
between 44 and 57 years [43,45,49,51,52]. However, it was
similar to that found in the studies of Rogers and Laine [41,47].
This fact is probably related to the type of oral rehabilitation
selected in our investigation – overdenture – as it is most
common in the elderly.
The positive genotype of interleukin-1 (allele 2 in both
889IL1A and +3953IL1B genes) was found to be associated
with the evaluated outcome (presence or absence of biological
complication in overdentures). In the univariate analysis
(Table 6), this variable revealed a statistically significant p
value (p=0.025) and so it was selected as one of the candidate
variables to integrate the final logistic regression model.
However, after model stabilization in the set of all the
Table 5 – Clinical variables related to peri-implant evaluation in both groups.
Group A (complication) Group B (successful) Total
Average plaque modified index Mean 1.178 0.550 0.897
Standard deviation 0.808 – 0.815
Median 1.375 0.000 0.889
Minimum 0.000 0.000 0.000
Maximum 3.000 2.000 3.000
Average bleeding modified index Mean 1.187 0.000 0.655
Standard deviation 0.557 – 0.723
Median 1.000 0.000 0.500
Minimum 0.250 0.000 0.000
Maximum 2.667 0.000 2.667
Mean probing depth (mm) Mean 3.782 2.698 3.296
Standard deviation 0.797 0.890 0.994
Median 3.704 2.584 3.282
Minimum 2.375 1.000 1.000
Maximum 5.429 4.750 5.429
Mean attached gingiva (mm) Mean 1.091 1.350 1.207
Standard deviation 1.001 0.781 0.911
Median 1.000 1.646 1.125
Minimum 0.000 0.000 0.000
Maximum 4.125 2.500 4.125
Fig. 2 – Sample distribution according to the peri-implant biological complications (N=58).
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variables, due to the unstableness related to its inclusion, the
interleukin-1 genotype was ultimately not included in the final
model.
In fact, our results of an association between a positive IL-1
genotype and the presence of biological complications are
discordant with some similar studies [22,40,41,44,46,47],
probably due to the sample size or due to differences in the
division of the population sample into groups. However, it
should be noted that currently there is still no evidence to
support or refute an association between the positive
interleukin-1 genotype and the development of peri-implant
biological complications. The outcome (presence or absence of
complication in overdentures with dental implants) distribu-
tion revealed that biological complications were more associ-
ated with the presence of allele 2 of the IL1B gene (+3953). In
fact, it was the only statistically significant p value (p=0.023) in
the univariate analysis (Table 6). For this reason, this variable
integrated our final logistic regression model. In this investi-
gation, no significant association between the allelic or
genotypic composition of IL1RN and the outcome (presence
or absence of biological complications) was found.
Implant loss may be preceded by clinical signs related to the
mean probing depth and the implant metal exposure.
However, these signs correspond to variables very difficult
to apply to the final model because their assessment is very
subjective, as the mean probing depth is based on an average
and the metal exposure is not even commonly measurable. In
fact, in our final model, these variables showed an under-
estimated value, which may be caused by its subjective
assessment or by the limited number of cases in our study
(Table 7). Nevertheless, it should be noted that late implant
loss has been associated with genetic polymorphisms of
interleukin-1 (889IL1A, +3954IL1B, and VNTR IL1RN), either
alone or in combination. Although the 511IL1B gene
polymorphism was not investigated in our research, it was
reported to be associated with marginal bone loss around
dental implants [43,49]. It should be noted that this peri-
implant bone loss (corresponding to an early type) occurs
Table 6 – Univariate logistic regression analysis.
Variable B S.E. Wald df p value exp(B) CI at 95% for exp(B)
LL UL
Medical treatment 1.099 0.729 2.271 1 0.132 0.333 0.080 1.391
Surgery 1.248 0.723 2.984 1 0.084 3.485 0.845 14.366
Implant technique 0.766 0.671 1.305 1 0.253 2.152 0.578 8.015
Postsurgical 0.766 0.671 1.305 1 0.253 2.152 0.578 8.015
Average plaque modified index 1.084 0.386 7.886 1 0.005 2.956 1.387 6.298
Mean probing depth (PD) 1.633 0.464 12.407 1 0.000 5.121 2.064 12.709
Mean attached gingiva 0.322 0.300 1.157 1 0.282 0.724 0.403 1.303
Metal exposure 3.344 1.080 9.595 1 0.002 28.333 3.415 235.091
IL1A_allele2 0.686 0.553 1.537 1 0.215 1.985 0.671 5.871
IL1B_allele2 1.329 0.585 5.163 1 0.023 3.778 1.200 11.889
IL-1 Genotype 1.453 0.650 5.001 1 0.025 4.278 1.197 15.292
A. actinomycetemcomitans 0.557 0.596 0.875 1 0.350 1.746 0.543 5.615
B. forsythus 0.405 0.531 0.584 1 0.445 1.500 0.530 4.245
F. nucleatum 0.468 0.633 0.546 1 0.460 0.626 0.181 2.166
P. gingivalis 0.385 0.545 0.498 1 0.480 1.469 0.505 4.274
Maxillary edentulousness 1.110 0.543 4.186 1 0.041 3.035 1.048 8.789
Gingiva hypertrophy 1.056 0.614 2.954 1 0.086 2.874 0.862 9.576
B, logistic regression containing only the variable; S.E., estimated standard error for the estimated coefficient; Wald, Wald statistics; df, degrees
of freedom; p value, value associated with the statistical coefficient test; exp(B), estimated odds ratio; CI, confidence interval of 95% for odds ratio;
LL, lower limit; UL, upper limit.
Table 7 – Final model.
B S.E. Wald df p value exp(B) CI at 95% for exp(B)
LL UL
Mean probing depth (PD) 3.005 1.052 8.159 1 0.004 20.192 2.568 158.773
Metal exposure 6.247 2.385 6.859 1 0.009 516.567 4.817 55400.21
IL1B_allele2 3.224 1.331 5.864 1 0.015 25.118 1.849 341.264
Maxillary edentulousness 1.953 1.433 1.857 1 0.173 7.047 0.425 116.866
F. nucleatum 3.76 1.848 4.14 1 0.042 0.023 0.001 0.871
Constant 16.299 6.542 6.208 1 0.013
B, estimates for the slope coefficients of the univariate logistic regression model containing only this variable; S.E., estimated standard error for
the estimated coefficient; Wald, Wald statistics; df, degrees of freedom; p value, value associated with the statistical coefficient test; exp(B),
estimated odds ratio; CI, confidence interval of 95% for odds ratio; LL, lower limit; UL, upper limit.
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before the placement of the implant in function, and thus
should not be confused with the one that was evaluated in our
study. The peri-implant bone loss that occurs after implant
connection (late), often called periimplantitis, has been
studied by several authors and has been related to the
889IL1A and +3953IL1B gene polymorphisms [40–42,44,47,74].
Currently, there is a consensus in the literature regarding
the association of peri-implant health and periodontal tissues
with biofilm with few gram-positive cocci and rods, and the
fact that extensive areas of inflammation harbor large
numbers of Gram-negative anaerobic bacteria [75]. Neverthe-
less, some authors also reported that when integrated into a
biofilm, bacteria act in a complex way and may even act
contrary to how they act when alone, i.e., instead of acting
more aggressively, they act in cooperation [76–78]. In our study,
the F. nucleatum was the bacterium less often detected in cases
of periimplantitis and peri-implant mucositis. The absence of
this bacterium appears to be associated with cases of no
biological complications. When included in the logistic
regression analysis, together with other variables, the F.
nucleatum had a slightly protective influence on the possibility
of biological complications. This finding may result from the
individual characteristics of the studied sample, the type of
rehabilitation (overdenture) and the qualitative method used
in bacterial detection (present/absent). The detected protec-
tive mechanism of the F. nucleatum together with other
variables should be investigated in a more comprehensive
clinical context, with larger samples in both situations –
disease and peri-implant health.
The value found for maxillary edentulousness was signifi-
cantly associated with biological complications in the univari-
ate logistic regression (p=0.041) and, therefore, this variable
was a candidate to be included in the construction of the final
model (Table 6). Thus, in the final model, a positive value for
maxillary edentulousness means that the presence of biologi-
cal complications is associated with the highest classification
level of this variabletotal maxillary edentulousness. The risk
of a biological complication is seven times greater for a
situation of total maxillary edentulousness when compared
with a situation of partial maxillary edentulousness (Table 7).
Fig. 3 – Empirical ROC curve to the final model.
Table 8 – Statistics for ROC analysis.
Test variable Area S.E. p value CI at 95%
LL UL
Final model 0.950 0.027 0.000 0.898 1.000
The null hypothesis considers that the true value of the area is 0.5.
Test variable, estimated probability for the final model; Area, area
under the ROC curve; S.E., estimate of the standard error for the area;
p value, value associated with the statistical coefficient test; CI,
confidence interval of 95% for odds ratio; LL, lower limit; UL, upper
limit.
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The international literature on dental implants rehabilitations
and interleukin-1 genotype polymorphisms [40–49,51,52] does
not address aspects related to occlusion and level of
edentulousness of the subjects. In the study by Laine et al.,
58 of the included subjects were reported to be edentulous and
62 were dentate [47], but no association with IL1RN polymor-
phisms was reported. In the study by Gruica, individuals were
rehabilitated with single crowns or extensive fixed bridges,
suggesting that subjects were partially edentulous, but no
information is given regarding this parameter and the
genotypic profile of the sample [44]. Therefore, we think that
more evaluation studies of these genetic polymorphisms are
required, involving larger samples and a detailed evaluation of
the type of prosthesis and level of edentulousness.
Each regression coefficient of the logit model describes the
level of contribution of that risk factor. Thus, a positive
regression coefficient means that the presence of the factor
increases the likelihood of the outcome. On the other hand,
when the regression coefficient is negative, the presence of the
factor decreases the likelihood of the outcome. Accordingly,
when the coefficient is high, the factor strongly influences the
probability of the outcome, while if it is close to zero, the factor
has little influence on the probability of the result. The area
under the ROC curve is one of the most widely used indexes for
evaluating the model quality and, therefore, its discriminative
power. Also, this method was already used in the study of
models with implant fixed prostheses, with prediction value of
0.789 [73]. Thus, for example, an area under the ROC curve of
0.950 means that the model corresponds to the prediction in
95% of the cases, and so it can be considered a good fit
[22,72,73,79]. Finally, to assess the significance of the model
regarding the area under the ROC curve (AUC), its estimate is
compared with that occurring by chance, which corresponds
to an AUC=0.5.
More studies with bigger samples are required to construct
and validate this decision model so that it can become a valid
tool to assist clinicians in daily diagnosis and treatment
planning of oral rehabilitation with implant overdentures.
5. Conclusions
Biological complications in implant-supported overdentures
were found to be mostly associated with the presence of allele
2 of the IL1B gene (+3953). F. nucleatum had a slightly protective
influence on the possibility of biological complications in
implant-supported overdentures.
The model developed in this study could serve as a basis for
further improved models in a near future, aimed to assist
clinicians in the daily diagnosis and treatment planning
practice of oral rehabilitation with implant overdentures.
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